NCLEX-PN • PSYCHOSOCIAL INTEGRITY

Substance Use, Withdrawal, And Overdose Care

Mastering assessment, intervention, and pharmacological management for clients experiencing substance-related emergencies.

Historical Context & The Evolution of Substance Use Care

The clinical understanding of substance use disorders has undergone a profound transformation over the past two centuries. For much of Western medical history, excessive alcohol or drug use was viewed purely as a moral failing rather than a medical condition, and treatment often consisted of incarceration or institutionalization in asylums. The emergence of the disease model of addiction in the mid-twentieth century fundamentally shifted how clinicians approach assessment, withdrawal management, and overdose response. This paradigm shift is especially relevant for practical nurses, who frequently serve as the first point of contact for clients in acute substance-related crises and must integrate psychosocial support with evidence-based medical interventions.

1935
Founding of Alcoholics Anonymous
AA introduced the concept of alcoholism as a progressive condition requiring ongoing peer support, establishing the 12-step model that remains influential in recovery frameworks worldwide.
1956
AMA Declares Alcoholism a Disease
The American Medical Association officially classified alcoholism as a treatable disease, catalyzing insurance coverage and the development of specialized treatment facilities.
1971
Methadone Maintenance Approved
The FDA approved methadone maintenance treatment for opioid use disorder, marking one of the first evidence-based pharmacological approaches to addiction management.
2013
DSM-5 Redefines Substance Use Disorders
The DSM-5 replaced the separate categories of 'abuse' and 'dependence' with a unified substance use disorder spectrum graded as mild, moderate, or severe based on diagnostic criteria.
2023
Harm Reduction as Standard Practice
Federal agencies and nursing organizations increasingly endorse harm reduction strategies, including naloxone distribution, supervised consumption sites, and non-judgmental care approaches.

Today, practical nurses must answer a critical clinical question: how do we assess, stabilize, and support a client whose substance use has reached a point of physiological crisis—whether through active intoxication, dangerous withdrawal, or life-threatening overdose? This lesson addresses that question comprehensively, equipping you with the knowledge base required for the NCLEX-PN Psychosocial Integrity domain.

Core Principles of Substance Use, Withdrawal, and Overdose Care

Effective nursing care for substance-related conditions rests on several foundational principles that guide clinical assessment and intervention. Understanding these principles ensures that the practical nurse can differentiate between intoxication, withdrawal, and overdose presentations—three conditions that demand distinctly different interventions despite arising from the same underlying disorder. These principles also underscore the importance of a non-judgmental, patient-centered approach that treats the client with dignity while prioritizing physiological safety.

1

Tolerance & Physiological Dependence

Repeated substance exposure leads to neuroadaptation, requiring increasing doses to achieve the same effect (tolerance) and producing predictable physiological syndromes when the substance is abruptly reduced or discontinued (dependence).
2

Withdrawal as a Medical Emergency

Withdrawal from certain substances—particularly alcohol, benzodiazepines, and barbiturates—can be life-threatening. Seizures, delirium tremens, and cardiovascular collapse require immediate medical intervention and standardized assessment tools.
3

Overdose Recognition & Reversal

Overdose presents with substance-specific symptom clusters. Opioid overdose features respiratory depression and miosis; stimulant overdose causes hyperthermia and tachycardia. Rapid recognition and appropriate antidote administration save lives.
4

Harm Reduction Philosophy

Harm reduction acknowledges that abstinence may not be immediately achievable for every client and focuses on minimizing negative health consequences through strategies such as naloxone access, needle exchange, and motivational interviewing.
5

Therapeutic Communication

Clients with substance use disorders often experience shame, denial, and fear of judgment. Therapeutic communication techniques—open-ended questions, reflective listening, and empathy—build trust and facilitate honest assessment.
KEY TAKEAWAY
Think of substance dependence like a thermostat that has been recalibrated. The body adjusts its 'set point' to function with the substance present. When the substance is suddenly removed, the system overshoots in the opposite direction—much like removing a counterweight from a balanced scale causes it to tip violently. Withdrawal symptoms are the body's overcorrection as it struggles to recalibrate without the substance it has come to expect.

Visual Overview: Intoxication, Withdrawal, and Overdose Pathways

This diagram illustrates the progression from substance use to the three acute crisis states—intoxication, withdrawal, and overdose—each converging on common nursing interventions that prioritize physiological safety and psychosocial integrity.

The diagram above illustrates the clinical trajectory that a practical nurse must understand. Substance use begins as a voluntary behavior, but repeated exposure leads to neuroadaptive changes that produce tolerance and physiological dependence. Once a substance use disorder is established, three distinct crisis presentations can emerge. Intoxication reflects the acute pharmacological effects of the substance on the central nervous system. Withdrawal occurs when a dependent individual abruptly reduces or stops use, triggering a rebound response opposite to the drug's usual effects. Overdose represents a toxic dose that overwhelms the body's compensatory mechanisms and can rapidly progress to organ failure and death. All three pathways demand the same foundational nursing approach: ensuring airway, breathing, and circulation; performing standardized assessments; administering ordered pharmacological agents; and maintaining a therapeutic, non-judgmental presence.

Mechanisms of Withdrawal and Overdose

Neurobiological Basis of Withdrawal

When a substance is used chronically, the central nervous system adapts through neuroadaptation—the upregulation or downregulation of neurotransmitter receptors to maintain homeostasis in the presence of the drug. Central nervous system (CNS) depressants such as alcohol and benzodiazepines enhance gamma-aminobutyric acid (GABA) activity, which inhibits neural firing. Over time, the brain compensates by increasing excitatory glutamate receptors and decreasing inhibitory GABA receptors. When the depressant is suddenly removed, the brain is left in a hyperexcitable state, producing withdrawal symptoms such as tremors, seizures, tachycardia, hypertension, and in severe cases, delirium tremens. Conversely, stimulant withdrawal from agents like cocaine or amphetamines produces a 'crash' characterized by fatigue, depression, and hypersomnia—reflecting the depletion of dopamine and norepinephrine after sustained overactivity.

Overdose Pathophysiology by Drug Class

Overdose pathophysiology varies by substance class but consistently involves the overwhelming of normal physiological regulatory mechanisms. Opioid overdose is driven by excessive activation of mu-opioid receptors in the brainstem respiratory center, leading to progressive respiratory depression, hypoxia, and eventually respiratory arrest. The antidote, naloxone (Narcan), acts as a competitive antagonist at these receptors, displacing the opioid and rapidly restoring respiratory drive. Alcohol and benzodiazepine overdoses also cause CNS and respiratory depression, but the mechanism involves GABA-A receptor potentiation. Flumazenil reverses benzodiazepine overdose but is used cautiously because it may precipitate seizures in chronic benzodiazepine users. Stimulant overdose produces a sympathomimetic toxidrome—severe hypertension, hyperthermia, tachyarrhythmias, and potential for stroke or myocardial infarction—requiring supportive cooling, benzodiazepines for agitation, and careful hemodynamic monitoring.

⚠️ Clinical Alert: Life-Threatening Withdrawals
Among all substance classes, withdrawal from alcohol, benzodiazepines, and barbiturates can be fatal. Opioid withdrawal, while intensely uncomfortable, is generally not life-threatening in otherwise healthy adults. This distinction is critical for prioritizing medical interventions on the NCLEX-PN.
Comparison of withdrawal and overdose presentations across major substance classes
Substance ClassWithdrawal SymptomsOverdose SymptomsKey Antidote/Intervention
OpioidsRhinorrhea, lacrimation, piloerection, myalgia, diarrhea, restlessness, yawningRespiratory depression, miosis (pinpoint pupils), sedation, bradycardia, cyanosisNaloxone (Narcan)
AlcoholTremors, diaphoresis, tachycardia, hypertension, nausea, seizures, delirium tremens (48−72 hrs)Ataxia, slurred speech, respiratory depression, hypothermia, comaBenzodiazepines (chlordiazepoxide, lorazepam); thiamine IV
BenzodiazepinesAnxiety, insomnia, tremors, seizures, psychosis (similar to alcohol withdrawal)Excessive sedation, respiratory depression, hypotensionFlumazenil (use cautiously)
Stimulants (cocaine, amphetamines)Depression, fatigue, hypersomnia, increased appetite, psychomotor retardationHypertension, tachycardia, hyperthermia, agitation, seizures, stroke riskSupportive: benzodiazepines, cooling, no beta-blockers
CannabisIrritability, insomnia, decreased appetite, mild anxietyAnxiety, paranoia, tachycardia (rarely life-threatening)Supportive care, reassurance

Standardized Assessment Tools and Classification

Accurate and timely assessment is the cornerstone of safe withdrawal and overdose management. The practical nurse uses standardized instruments to quantify the severity of withdrawal, guide pharmacological dosing decisions, and document changes in the client's condition over time. Two tools are particularly high-yield for NCLEX-PN: the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) and the Clinical Opiate Withdrawal Scale (COWS). These validated scoring systems transform subjective clinical observations into objective numeric scores that drive treatment protocols.

Side-by-side comparison of the CIWA-Ar for alcohol withdrawal and the COWS for opioid withdrawal. Note the severity thresholds that guide medication administration in symptom-triggered protocols.

The CIWA-Ar is administered at regular intervals—typically every one to two hours—and the resulting score determines whether symptom-triggered benzodiazepine dosing is warranted. A score of 8 or below generally indicates mild withdrawal that can be managed with supportive care alone, while a score of 20 or above signals severe withdrawal requiring aggressive pharmacological intervention and close monitoring for seizures and delirium tremens. The COWS operates on a similar principle for opioid withdrawal and is essential for determining the appropriate timing to initiate medication-assisted treatment (MAT) with buprenorphine or methadone. Initiating buprenorphine too early—before the COWS score reaches at least 8 to 12—can precipitate withdrawal because buprenorphine is a partial agonist that displaces full agonists from opioid receptors.

Alcohol Withdrawal Timeline
Tremors, Anxiety (6−12 hrs)
Hallucinations (12−24 hrs)
Seizures (24−48 hrs)
Delirium Tremens (48−72+ hrs)
Last Drink72+ Hours

Worked Example: Managing Alcohol Withdrawal Using CIWA-Ar

The following scenario demonstrates how a practical nurse applies the CIWA-Ar protocol in a clinical setting to guide withdrawal management for a client admitted with a history of chronic alcohol use.

Clinical Scenario: Mr. J, 52-year-old Male — Alcohol Withdrawal
1
Step 1 — Gather Clinical DataMr. J is admitted to the medical-surgical unit 10 hours after his last alcoholic drink. He reports daily consumption of approximately one liter of vodka for the past 8 years. On admission, his vital signs are: BP 162/98, HR 112, T 99.4°F, RR 22. He appears diaphoretic, his hands exhibit a visible tremor when extended, and he reports feeling 'nervous and shaky.' He is oriented to person and place but unsure of the date.
Clinical picture: elevated vitals, tremor, diaphoresis, mild disorientation — consistent with alcohol withdrawal
2
Step 2 — Administer CIWA-Ar AssessmentThe nurse completes the CIWA-Ar scoring: Nausea/Vomiting = 3 (mild nausea, no vomiting); Tremor = 4 (moderate, visible with arms extended); Paroxysmal Sweats = 4 (beads on forehead); Anxiety = 4 (moderately anxious, guarded); Agitation = 3 (fidgeting, restless); Tactile Disturbances = 1 (mild itching/numbness); Auditory Disturbances = 1 (mildly harsh sounds); Visual Disturbances = 0; Headache = 2 (mild); Orientation/Clouding = 2 (uncertain about date).
CIWA-Ar Total Score: 24 — Severe Withdrawal
3
Step 3 — Implement Symptom-Triggered ProtocolPer the provider's standing order, a CIWA-Ar score ≥ 20 triggers administration of lorazepam 2 mg IV. The nurse also ensures seizure precautions are in place: padded side rails up, suction at bedside, oxygen readily available. Thiamine 100 mg IV is administered before any glucose-containing fluids to prevent Wernicke encephalopathy. The nurse documents the CIWA-Ar score and plans to reassess in 1 hour.
Interventions: Lorazepam 2 mg IV, seizure precautions, thiamine 100 mg IV, reassess CIWA-Ar in 1 hour
4
Step 4 — Reassess and AdjustOne hour later, the nurse re-administers the CIWA-Ar. Mr. J's tremor has decreased (score = 2), diaphoresis has improved (score = 2), anxiety is reduced (score = 2), and he can now state the correct date (orientation = 0). The new total CIWA-Ar score is 14 (moderate withdrawal). Per protocol, lorazepam 1 mg IV is administered. The nurse continues hourly monitoring and documents the downward trend, indicating the protocol is effective.
CIWA-Ar dropped from 24 → 14; continue monitoring, reduced benzodiazepine dose per protocol
5
Step 5 — Psychosocial Support and Discharge PlanningAs Mr. J stabilizes (CIWA-Ar < 8 for three consecutive assessments), the nurse initiates therapeutic communication about his substance use history, using open-ended questions and motivational interviewing techniques. The nurse provides education about community resources including AA meetings, outpatient counseling, and medication-assisted treatment options (naltrexone, disulfiram, or acamprosate). A social work referral is placed, and the nurse documents the client's expressed readiness for change using the Stages of Change model.
Holistic care: medical stabilization + psychosocial intervention + discharge planning = comprehensive SUD nursing care

Pharmacological Interventions: Strengths and Limitations

Pharmacological management forms a critical component of substance use disorder care. The practical nurse must understand the mechanism, indications, and nursing considerations for key medications used in withdrawal management, overdose reversal, and long-term relapse prevention. However, each agent carries specific strengths and limitations that influence clinical decision-making.

Key pharmacological agents in substance use disorder care
MedicationIndicationStrengthsLimitations / Nursing Considerations
Naloxone (Narcan)Opioid overdose reversalRapid onset (2−5 min IV); available IM, IN, IV; can be administered by laypersons; no abuse potentialShort half-life (30−90 min) — may wear off before opioid, requiring repeat doses; may precipitate acute withdrawal with severe agitation
Lorazepam (Ativan)Alcohol/benzo withdrawal; stimulant OD agitationNo active metabolites (safer in liver disease); versatile route administration (PO, IM, IV)Risk of respiratory depression, especially with concurrent opioid use; requires careful dose titration using CIWA-Ar
MethadoneOpioid use disorder maintenanceFull agonist; long half-life provides 24-hr coverage; reduces cravings and illicit useDispensed only through certified opioid treatment programs; risk of QT prolongation; respiratory depression risk
Buprenorphine (Suboxone)Opioid use disorder maintenance/detoxPartial agonist with ceiling effect (lower OD risk); can be prescribed in office settings; combined with naloxone to deter IV misuseMust wait until sufficient withdrawal (COWS ≥ 8−12) before initiating or precipitated withdrawal occurs; sublingual administration
Disulfiram (Antabuse)Alcohol relapse preventionCreates aversive reaction with alcohol (flushing, nausea, vomiting); psychological deterrentRequires strict adherence and motivation; can cause severe reaction if alcohol is consumed; hepatotoxicity risk
KEY TAKEAWAY
Think of naloxone as an emergency 'eviction notice' for opioid molecules at receptor sites—it physically displaces them, but because its lease is shorter than most opioids, the evicted molecules may return once naloxone wears off. This is why patients must be monitored continuously after naloxone administration and may require repeated dosing. The clinical implication is clear: never discharge or reduce monitoring for a client simply because one naloxone dose restored breathing.

Connection to Advanced Practice: Co-Occurring Disorders and Trauma-Informed Care

The foundational principles of substance use, withdrawal, and overdose management explored in this lesson directly connect to more advanced clinical frameworks that the practical nurse will encounter in specialized settings. Two concepts are particularly important: the management of co-occurring disorders (also called dual diagnosis) and the application of trauma-informed care principles. Research consistently demonstrates that approximately 50% of individuals with a substance use disorder also meet criteria for at least one concurrent mental health diagnosis, most commonly major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, or bipolar disorder. The intersection of these conditions complicates both assessment and treatment, as psychiatric symptoms can mimic or mask withdrawal presentations, and withdrawal itself can trigger or exacerbate underlying psychiatric conditions.

PN-Level vs. Advanced Practice approaches to substance use care
ConceptPN-Level ApplicationAdvanced/RN-Level Application
AssessmentAdminister CIWA-Ar/COWS; report changes in mental status; document objectivelyConduct comprehensive psychiatric evaluations; differentiate substance-induced vs. independent psychiatric disorders
PharmacologyAdminister ordered medications; monitor for side effects; educate on MAT basicsManage complex polypharmacy; titrate psychotropic + MAT regimens; prescriptive authority (NP)
Therapeutic CommunicationUse motivational interviewing basics; provide non-judgmental support; identify stage of changeLead group therapy; implement CBT/DBT interventions; conduct family systems therapy
Trauma-Informed CareAsk 'What happened to you?' instead of 'What's wrong with you?'; avoid re-traumatizing procedures; ensure physical and emotional safetyDesign program-level trauma-informed policies; implement EMDR and trauma-focused CBT; lead organizational culture change

As you progress in your nursing career, the assessment and intervention skills you develop at the PN level will serve as the clinical foundation upon which advanced practice competencies are built. The practical nurse's role in early detection, accurate documentation, and compassionate first-contact care is often the critical link between a client entering the healthcare system in crisis and their eventual engagement with long-term recovery services. Familiarity with the Stages of Change model—precontemplation, contemplation, preparation, action, and maintenance—helps the PN meet clients where they are rather than imposing premature expectations of abstinence.

Practice Problems

PROBLEM 1CONCEPTUAL
A nursing student asks why opioid withdrawal is described as 'intensely uncomfortable but generally not life-threatening,' while alcohol withdrawal can be fatal. Explain the neurobiological basis for this difference.
PROBLEM 2BASIC CALCULATION
A client undergoing alcohol withdrawal receives a CIWA-Ar assessment with the following scores: Nausea = 4, Tremor = 5, Sweats = 3, Anxiety = 6, Agitation = 4, Tactile = 2, Auditory = 2, Visual = 1, Headache = 3, Orientation = 2. Calculate the total CIWA-Ar score and determine the severity category. Based on a symptom-triggered protocol, what nursing action is indicated?
PROBLEM 3INTERMEDIATE
A client with a known history of heroin use presents to the emergency department with respiratory rate of 6, pinpoint pupils, oxygen saturation of 78%, and Glasgow Coma Scale of 6. Naloxone 0.4 mg IV is administered. Within 3 minutes, the client's respiratory rate increases to 14 and SpO₂ rises to 94%, but the client becomes extremely agitated, diaphoretic, and nauseated. Explain what is occurring and describe the priority nursing interventions for the next 2 hours.
PROBLEM 4APPLIED
A 28-year-old client with a COWS score of 6 (mild withdrawal) is scheduled to begin buprenorphine/naloxone (Suboxone) induction. The client is anxious and asks the nurse to give the medication immediately to 'make the withdrawal stop.' The provider's order states to initiate buprenorphine when COWS ≥ 12. How should the practical nurse respond, and what is the clinical rationale for the delayed initiation?
PROBLEM 5CRITICAL THINKING
You are caring for a client who was admitted for alcohol withdrawal management and is now stabilized (CIWA-Ar consistently < 8 for 24 hours). During discharge planning, the client states: 'I know I drink too much, but I'm not sure I'm ready to quit completely. My wife thinks I should go to rehab, but I think I can cut back on my own.' Using the Stages of Change model, identify the client's current stage, describe the most appropriate nursing communication strategy, and explain why pushing for immediate abstinence would be therapeutically counterproductive.

Lesson Summary

Substance use disorders represent a spectrum of conditions rooted in neuroadaptation and physiological dependence that can produce three distinct clinical crises: intoxication, withdrawal, and overdose. The practical nurse uses standardized assessment tools—the CIWA-Ar for alcohol and the COWS for opioids—to quantify withdrawal severity and guide symptom-triggered pharmacological interventions. Critical antidotes include naloxone for opioid overdose and benzodiazepines for alcohol and sedative-hypnotic withdrawal. Remember that withdrawal from alcohol, benzodiazepines, and barbiturates can be life-threatening, while opioid withdrawal, though profoundly distressing, is rarely fatal in otherwise healthy individuals.

Beyond physiological management, effective nursing care demands a non-judgmental, patient-centered approach grounded in therapeutic communication and harm reduction philosophy. The Stages of Change model (precontemplation, contemplation, preparation, action, maintenance) guides the nurse in meeting clients at their current level of readiness. Medication-assisted treatment with methadone, buprenorphine, or naltrexone represents the evidence-based standard for opioid use disorder management, while disulfiram, naltrexone, and acamprosate support alcohol use disorder recovery. The practical nurse's role integrates all of these elements—acute stabilization, accurate assessment, pharmacological support, and compassionate psychosocial care—to promote both immediate safety and long-term recovery.

Varsity Tutors • NCLEX-PN • Substance Use, Withdrawal, And Overdose Care